DIALYSIS · Loading…
DIALYSIS · CCN 672773
DaVita Cloverleaf Dialysis
HOUSTON, TX 77015
DialysisProfitDaVita
$3.4M
TOTAL REVENUE
19.5%
OPERATING MARGIN
3 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL
Cost report financials (FY2024)
- Net patient revenue
- $3.4M
- Total costs
- $2.7M
- Operating income (rev − costs)
- $664K
- Operating margin
- 19.5%
- Total charges
- $4.2M
- Total treatments
- 7,918
- Dialysis stations
- 12
Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.
02 — QUALITY MEASURES
12 quality measures
| Measure | Score | Denominator | Period |
|---|---|---|---|
Standardized ED Visits Within 30 Days of Hospital Discharge DFC_ED30 | 0.33 | 25 | — |
Fistula Rate DFC_FISTULA_RATE | 65.7 | 45 | — |
Five Star Rating DFC_FIVE_STAR | 3 | — | — |
First Year Standardized Kidney Transplant Waitlist Ratio DFC_FYSWR | 0.67 | 25 | — |
Healthcare Worker COVID-19 Vaccination Adherence DFC_HCP_VACC | 4 | — | — |
Patient Hospitalization Rate DFC_HOSPITALIZATION_RATE | 173.3 | 55 | — |
Standard Infection Ratio (SIR) DFC_INFECTION_RATIO | 0 | — | — |
Percentage of Adult Patients with Long Term Catheter in Use DFC_LONG_CATHETER | 18 | 45 | — |
Patient Survival (Mortality Rate) DFC_MORTALITY_RATE | 25.9 | 213 | — |
Percentage of Prevalent Patients Waitlisted for Kidney Transplant DFC_PPPW | 20.1 | 70 | — |
Patient Hospital Readmission Rate DFC_READMISSION_RATE | 33.2 | 61 | — |
Standardized ED Visits Ratio DFC_SEDR | 0.83 | 19 | — |